Consolidated and emerging inflammatory markers in coronary artery disease

doi:10.5493/wjem.v5.i1.21

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13036)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

771

WORD

424

HTML

6543

Figures (1-3)

233

Sum=7971

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

1102

Download

1556

Sum=2658

Publishing Process of This Article

Item

Count

Browse

1249

Download

1158

Sum=2407

Feb 20, 2015 (publication date) through Feb 5, 2025

Times Cited of This Article

Times Cited (47)

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Exp Med. Feb 20, 2015; 5(1): 21-32
Published online Feb 20, 2015. doi: 10.5493/wjem.v5.i1.21

Full Size Figure Download Figure

Figure 3 Regression analysis of LOX-1. From Lubrano et al[76], 2008. Positive association between circulating levels of LOX-1 and inflammatory markers. TNF-α: Tumor necrosis factor alpha; IL: Interleukin; CRP: C-reactive protein; LOX-1: Lectin-like oxidized low-density lipoprotein receptor-1.

Citation: Lubrano V, Balzan S. Consolidated and emerging inflammatory markers in coronary artery disease. World J Exp Med 2015; 5(1): 21-32
URL: https://www.wjgnet.com/2220-315X/full/v5/i1/21.htm
DOI: https://dx.doi.org/10.5493/wjem.v5.i1.21